Astria Therapeutics (ATXS) Net Income: 2013-2018
Historic Net Income for Astria Therapeutics (ATXS) over the last 6 years, with Dec 2018 value amounting to -$26.0 million.
- Astria Therapeutics' Net Income fell 6.65% to -$5.9 million in Q4 2018 from the same period last year, while for Dec 2018 it was -$26.0 million, marking a year-over-year increase of 5.05%. This contributed to the annual value of -$26.0 million for FY2018, which is 4.93% up from last year.
- According to the latest figures from FY2018, Astria Therapeutics' Net Income is -$26.0 million, which was up 4.93% from -$27.4 million recorded in FY2017.
- Astria Therapeutics' Net Income's 5-year high stood at -$21.9 million during FY2014, with a 5-year trough of -$36.2 million in FY2016.
- Over the past 3 years, Astria Therapeutics' median Net Income value was -$27.4 million (recorded in 2017), while the average stood at -$29.9 million.
- Per our database at Business Quant, Astria Therapeutics' Net Income slumped by 49.12% in 2015 and then grew by 24.22% in 2017.
- Yearly analysis of 5 years shows Astria Therapeutics' Net Income stood at -$21.9 million in 2014, then plummeted by 49.12% to -$32.6 million in 2015, then declined by 10.77% to -$36.2 million in 2016, then increased by 24.22% to -$27.4 million in 2017, then climbed by 4.93% to -$26.0 million in 2018.